iNtRON Biotechnology, Inc.
Develops drugs, diagnostics, and reagents for infectious diseases and AMR.
048530 | KO
Overview
Corporate Details
- ISIN(s):
- KR7048530000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 중원구 사기막골로 137 중앙인더스피아 5차 701~704호, 성남시
- Website:
- https://intronbio.com:6001
- Sector:
- Manufacturing
Description
iNtRON Biotechnology, Inc. is a biotechnology company specializing in solutions for infectious diseases. Its core activities are centered on three main pillars: bio-new drugs, molecular diagnostics, and molecular biology reagents. The company's therapeutic pipeline focuses on developing novel treatments for drug-resistant super-bacteria, creating antibiotic alternatives and other bio-active agents to address the challenge of antimicrobial resistance (AMR). In its diagnostics division, iNtRON develops and manufactures detection kits and assays, primarily based on real-time PCR technology, for the rapid identification of infectious organisms. The company also provides a range of molecular reagents for research and has commercialized antibiotic alternative products for the animal health market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-01-26 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.4 KB | ||
| 2024-01-26 00:00 |
주주총회소집결의
|
Korean | 6.8 KB | ||
| 2024-01-26 00:00 |
현금ㆍ현물배당결정
|
Korean | 8.4 KB | ||
| 2023-12-15 00:00 |
[기재정정]분기보고서 (2023.09)
|
Korean | 1.5 MB | ||
| 2023-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2023-11-24 00:00 |
[기재정정]사업보고서 (2022.12)
|
Korean | 1.6 MB | ||
| 2023-11-14 00:00 |
분기보고서 (2023.09)
|
Korean | 1.4 MB | ||
| 2023-09-01 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 10.4 KB | ||
| 2023-08-11 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 80.3 KB | ||
| 2023-08-11 00:00 |
반기보고서 (2023.06)
|
Korean | 1.3 MB | ||
| 2023-08-03 00:00 |
주요사항보고서(자기주식취득신탁계약해지결정)
|
Korean | 23.9 KB | ||
| 2023-08-03 00:00 |
주요사항보고서(자기주식취득신탁계약해지결정)
|
Korean | 23.9 KB | ||
| 2023-08-03 00:00 |
신탁계약해지결과보고서
|
Korean | 14.8 KB | ||
| 2023-08-03 00:00 |
신탁계약해지결과보고서
|
Korean | 14.2 KB | ||
| 2023-07-06 00:00 |
신탁계약해지결과보고서
|
Korean | 15.5 KB |
Automate Your Workflow. Get a real-time feed of all iNtRON Biotechnology, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for iNtRON Biotechnology, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for iNtRON Biotechnology, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
